Treatment of Intractable Diabetic Macular Edema With Pegaptanib Versus Bevacizumab, Both in Combination With Dexamethasone

Kansas Journal of Medicine
doi 10.17161/kjm.v5i3.11416
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The University of Kansas

Related search

Macular Laser Grid Alone Versus Combined With Intravitreal Triamcinolone Plus Bevacizumab for Diabetic Macular Edema

Journal of Pharmaceutical and Scientific Innovation
2013English

Dexamethasone Implant in Diabetic Macular Edema

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2016English

Comparison of Intravitreal Bevacizumab Upload Followed by a Dexamethasone Implant Versus Dexamethasone Implant Monotherapy for Retinal Vein Occlusion With Macular Edema

Ophthalmologica
MedicineOphthalmologySensory Systems
2012English

Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment

Ophthalmology
Ophthalmology
2012English

Analysis of Factors Related to Early Macular Edema Recurrence After Intravitreal Dexamethasone Implant Treatment in Diabetic Macular Edema

Acta Ophthalmologica
MedicineOphthalmology
2018English

Bevacizumab Versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated With Branch Retinal Vein Occlusion

Korean journal of ophthalmology : KJO
Medicine
2018English

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

Ophthalmology
Ophthalmology
2016English

Combination Therapy for Diabetic Macular Edema

Journal of Ophthalmology
Ophthalmology
2012English

Combined Vitrectomy and Intravitreal Injection Versus Combined Laser and Injection for Treatment of Intractable Diffuse Diabetic Macular Edema

Clinical Ophthalmology
Ophthalmology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy